IL-17 not only activates synovial cells to secrete inflammatory mediators, exacerbating joint inflammation (15, 16), but also induces the production of pro-inflammatory factors by fibroblasts and endothelial cells, stimulates smooth muscle cell proliferation, and promotes arterial wall inflammation, thereby driving the progression of atherosclerosis (15). This evidence concerns the gene IL17A and atherosclerosis.